Thirty-day mortality in UK patients with community-onset and hospital-acquired meticillin-susceptible Staphylococcus aureus bacteraemia

Journal of Hospital Infection

Volumn 84, Issue 2, 2013, Pages 143-150

  Melzer, M ^a   Welch, C ^b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bacteraemia; Community onset; Hospital acquired; Meticillin susceptible Staphylococcus aureus; Mortality

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CHARLSON COMORBIDITY INDEX; CHILD; DEMOGRAPHY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFANT; INFECTIOUS ARTHRITIS; INTRAVASCULAR CATHETER; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORTALITY; PRESCHOOL CHILD; SCHOOL CHILD; SKIN INFECTION; SOFT TISSUE INFECTION; SPONDYLITIS; STAPHYLOCOCCAL BACTEREMIA; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; GREAT BRITAIN; HUMANS; INFANT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84878123515     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.12.013     Document Type: Article

References (36)

1. Asgeirsson H., Kristjansson M., Kristinsson K., Gudlaugsson O. Staphylococcus aureus bacteraemia - nationwide assessment of treatment adequacy and outcome. J Infect 2011, 62:339-346.
2. Topeli A., Unal S., Akalin H.E. Risk factors influencing clinical outcome in Staphylococcus aureus bacteraemia in a Turkish hospital. Int J Antimicrob Agents 2000, 14:57-63.
3. Lin J.C., Yeh K.M., Peng M.Y., Chang F.Y. Community-acquired methicillin-resistant Staphylococcus aureus bacteraemia in Taiwan: risk factors for acquisition, clinical features and outcomes. J Microbiol Immunol 2004, 37:24-28.
4. Melzer M., Eykyn S.J., Gransden W.R., Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteraemia. Clin Infect Dis 2003, 37:1453-1460.
5. Turnidge J.D., Kotsanas D., Munchhof W., et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 2009, 191:368-373.
6. Chia J.W., Hsu L.Y., Tambyah P.A. Epidemiology and outcomes of community-acquired methicillin-susceptible Staphylococcus aureus bacteraemia in a university hospital in Singapore. BMC Infect Dis 2008, 8:14.
7. Kaech C., Elzi L., Sendi P., et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary care centre. Clin Microbiol Infect 2006, 12:345-352.
8. Hawkins C., Huang J., Jin N., et al. Persistent Staphylococcus aureus bacteraemia: an analysis of risk factors and outcomes. Archs Intern Med 2007, 167:1861-1867.
9. Libert M., Elkholti M., Massaut J., et al. Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgium university hospital. J Hosp Infect 2008, 68:17-24.
10. Hill P.C., Birch M., Chambers S., et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 2001, 31:97-103.
11. Khatib R., Johnson L.B., Fakih M.G., et al. Persistence in Staphylococcus aureus bacteraemia: incidence, characteristics of patients and outcome. Scand J Infect Dis 2006, 38:7-14.
12. Lyytikauinen O., Ruotsalainen E., Jarvinen A., Valtonen V., Ruutu P. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland. 1995-2001. Eur J Clin Microbiol Infect Dis 2005, 24:399-404.
13. Maradonna J.A., Carton J.A., Lopez-Alonso J., Carcaba V., Nuno F.J., Arribas J.M. Comparative study of community versus hospital-acquired Staphylococcus aureus bacteraemia. Eur J Med 1992, 1:113-115.
14. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
15. McGregor J.C., Rich S.E., Harris A.D., et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteraemic patients. Clin Infect Dis 2007, 45:329-337.
16. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30:536-555.
17. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
18. Paterson D.L., Ko Ween-Chien, Gottberg A.V., et al. International prospective study of Klebsiella pneumoniae bacteraemia: implications of extended spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004, 140:26-32.
19. Andrew J.M. BSAC standardised disc susceptibility testing method (version 6). J Antimicrob Chemother 2007, 60:20-41.
20. Skov R., Smyth R., Clausen M., et al. Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2003, 52:204-207.
21. Thwaites G.E. United Kingdom Clinical Infection Research Group (UKCIRG). The management of Staphylococcus aureus bacteraemia in the United Kingdom and Vietnam: a multi-centre evaluation. PLoS One 2010, 5:e14170.
22. Gransden W.R., Eykyn S.J., Phillips I. Staphylococcus aureus bacteraemia: 400 episodes in St Thomas's Hospital. BMJ (Clin Res Ed) 1985, 290:505-508.
23. Price J., Baker G., Heath I., et al. Clinical and microbiological determinants of outcome in Staphylococcus aureus. Int J Microbiol 2010, 2010:854-858.
24. Wyllie D.H., Crook D.W., Peto T.E. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006, 333:468.
25. Bassetti M., Trecarichi E.M., Mesini A., et al. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2012, 18:862-869.
26. Linuma Y., Saito T., Matsumura Y., et al. Close cooperation between infectious diseases physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2010, 16:1783-1788.
27. Kim J., Gregson D.B., Ross T., Laupland K.B. Time to blood culture positivity in Staphylococcus aureus bacteraemia: association with 30-day mortality. J Infect 2010, 61:197-204.
28. Verhagen D.W., van der Meer J.T., Hamming T., deJong M.D., Speelman P. Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study. Scand J Infect Dis 2003, 35:459-463.
29. Bryan C.S., Kirkhart B., Brenner E.R. Staphylococcus bacteraemia: current patterns in non-university hospitals. South Med J 1984, 77:693-696.
30. Lautenschlanger S., Herzog C., Zimmerli W. Course and outcome of bacteraemia due to Staphylococcus aureus: evaluation of different case definitions. Clin Infect Dis 1993, 16:567-573.
31. Wilcox P.A., Rayner B.L., Whitelaw D.A. Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs. Q J Med 1998, 91:41-47.
32. Wang J.L., Chen S.Y., Wang J.T., et al. Comparison of both clinical features and mortality risk associated with bacteraemia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008, 46:799-806.
33. Bader M.S. Staphylococcus aureus bacteraemia in older patients: predictors of 7-day mortality and infection with a methicillin-resistant strain. Infect Control Hosp Epidemiol 2006, 27:1219-1225.
34. Davis S.L., Perii M.B., Donabedian S.M., et al. Epidemiology and outcomes of community-associated Staphylococcus aureus infection. J Clin Microbiol 2007, 45:1705.
35. Kreienbuehl L., Charbonney E., Eggimann P. Community-acquired necrotizing pneumonia due to meticillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports. Ann Intensive Care 2011, 1:52.
36. Muttaiyah S., Coombs G., Pandev S., et al. Incidence, risk factors and outcomes in Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus infections in Auckland, New Zealand. J Clin Microbiol 2010, 48:3470-3474.